181 related articles for article (PubMed ID: 34879057)
21. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
22. 1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.
Washington MN; Kim JS; Weigel NL
Prostate; 2011 Jan; 71(1):98-110. PubMed ID: 20632309
[TBL] [Abstract][Full Text] [Related]
23. Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis.
Guidi CJ; Mudhasani R; Hoover K; Koff A; Leav I; Imbalzano AN; Jones SN
Cancer Res; 2006 Aug; 66(16):8076-82. PubMed ID: 16912184
[TBL] [Abstract][Full Text] [Related]
24. Context dependent roles for RB-E2F transcriptional regulation in tumor suppression.
Thwaites MJ; Cecchini MJ; Passos DT; Zakirova K; Dick FA
PLoS One; 2019; 14(1):e0203577. PubMed ID: 30703085
[TBL] [Abstract][Full Text] [Related]
25. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
[TBL] [Abstract][Full Text] [Related]
26. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
27. αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation.
Petrovic V; Malin D; Cryns VL
Breast Cancer Res Treat; 2013 Apr; 138(2):415-25. PubMed ID: 23471649
[TBL] [Abstract][Full Text] [Related]
28. A masked initiation region in retinoblastoma protein regulates its proteasomal degradation.
Tomita T; Huibregtse JM; Matouschek A
Nat Commun; 2020 Apr; 11(1):2019. PubMed ID: 32332747
[TBL] [Abstract][Full Text] [Related]
29. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.
Rajasekaran N; Jung HS; Bae SH; Chelakkot C; Hong S; Choi JS; Yim DS; Oh YK; Choi YL; Shin YK
Neoplasia; 2017 Oct; 19(10):735-749. PubMed ID: 28843398
[TBL] [Abstract][Full Text] [Related]
30. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.
Vooijs M; van der Valk M; te Riele H; Berns A
Oncogene; 1998 Jul; 17(1):1-12. PubMed ID: 9671308
[TBL] [Abstract][Full Text] [Related]
31. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
[TBL] [Abstract][Full Text] [Related]
32. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
33. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest.
Puga A; Barnes SJ; Dalton TP; Chang Cy; Knudsen ES; Maier MA
J Biol Chem; 2000 Jan; 275(4):2943-50. PubMed ID: 10644764
[TBL] [Abstract][Full Text] [Related]
34. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.
Ziebold U; Lee EY; Bronson RT; Lees JA
Mol Cell Biol; 2003 Sep; 23(18):6542-52. PubMed ID: 12944480
[TBL] [Abstract][Full Text] [Related]
35. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
36. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
[TBL] [Abstract][Full Text] [Related]
37. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.
Akeno N; Miller AL; Ma X; Wikenheiser-Brokamp KA
Oncogene; 2015 Jan; 34(5):589-99. PubMed ID: 24469052
[TBL] [Abstract][Full Text] [Related]
38. The Retinoblastoma pathway regulates stem cell proliferation in freshwater planarians.
Zhu SJ; Pearson BJ
Dev Biol; 2013 Jan; 373(2):442-52. PubMed ID: 23123964
[TBL] [Abstract][Full Text] [Related]
39. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY
Oncogene; 1994 Apr; 9(4):1021-7. PubMed ID: 8134105
[TBL] [Abstract][Full Text] [Related]
40. Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.
Sangwan M; McCurdy SR; Livne-Bar I; Ahmad M; Wrana JL; Chen D; Bremner R
Oncogene; 2012 Nov; 31(48):5019-28. PubMed ID: 22286767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
